Search
Search Results
##search.searchResults.foundPlural##
-
Guest Editor: G. Castaman AGING WITH HEMOPHILIA: THE CHALLENGE OF APPROPRIATE DRUG PRESCRIPTION Hemophilia and aging
3132PDF: 1554HTML: 337 -
FEASIBILITY AND OUTCOME OF FIRST-LINE AUTOTRANSPLANT-BASED TREATMENT IN NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS AGED > 65 YEARS: MONOCENTRIC RETROSPECTIVE REAL-WORLD ANALYSIS Outcomes of ASCT in NDMM elderly fit patients
1172PDF: 697Html: 190 -
The MINI-POLATUZUMAB VEDOTINE PLUS CHP (POLA-R-CHP) VS. MINI-R-CHOP IN PATIENTS OVER 80 YEARS OF AGE WITH DIFFUSE LARGE B-CELL LYMPHOMA: A RETROSPECTIVE, PROPENSITY SCORE-MATCHED ANALYSIS STRATIFIED BY SIMPLIFIED FRAILTY SCORE PolaRCHP vs. RCHOP for older patients
1632PDF: 600HTML: 366 -
THERAPY-RELATED MYELOID NEOPLASM IN NON-HODGKIN LYMPHOMA SURVIVORS
2873PDF: 870HTML: 2338 -
TREATMENT RECOMMENDATIONS FOR CHRONIC MYELOID LEUKEMIA
3600PDF: 1724HTML: 4105 -
I INCREASED RISK OF LYMPHOMA IN MEN INFECTED WITH TUBERCULOSIS
1374PDF: 583HTML: 444 -
OUTCOME OF PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA RELAPSING AFTER AUTOLOGOUS TRANSPLANT BEFORE AVAILABILITY OF CAR-T CELL TREATMENT Outcome of DLBCL patients relapsing after ASCT
1704HTML: 436PDF: 1051Suppl. Files: 540 -
The labyrinth of pyrexia of unknown origin: A case of intravascular B cell lymphoma
2100PDF: 762HTML: 2470Untitled: 224Figure 1 a: 230Figure 1 b: 229Fig 1 c: 211Figure 1 d: 282 -
REFRACTORY THROMBOCYTOPENIA AND NEUTROPENIA: A DIAGNOSTIC CHALLENGE
13091PDF: 1801HTML: 4385Cover letter: 317Figure 1: 340 -
PATHOBIOLOGY OF HODGKIN LYMPHOMA
3794PDF: 1829HTML: 5995Fig1-Ag-Pil: 302Ag-Pil Fig.2: 297 -
HHVs AND LYMPHOPROLIFERATIVE DISORDERS
1608PDF: 913HTML: 3158 -
NEW TREATMENTS FOR MYELODYSPLASTIC SYNDROMES
2182PDF: 2059HTML: 816 -
SOCIOECONOMIC STATUS IS GLOBALLY A PROGNOSTIC FACTOR FOR OVERALL SURVIVAL OF MULTIPLE MYELOMA PATIENTS; SYNTHESIS OF STUDIES AND REVIEW OF THE LITERATURE SES as prognostic factor for myeloma survival
2387PDF: 956HTML: 391 -
INFECTIOUS COMPLICATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA
3681PDF: 1508HTML: 2758 -
LYON-UNIVERSITY HOSPITAL EXPERIENCE WITH GEMTUZUMAB OZOGAMICIN THERAPY IN ACUTE MYELOID LEUKEMIA: A ‘REAL-LIFE’ STUDY Gemtuzumab ozogamicin in AML
2080PDF: 1276HTML: 359 -
VITAMIN D STATUS IN THALASSEMIA MAJOR: AN UPDATE
2961PDF: 1220HTML: 2710 -
AGING WITH THALASSEMIA AND SICKLE CELL DISEASE: A GERONTOLOGICAL MODEL OF ACCELERATED MULTIMORBIDITY AND FUNCTION-CENTERED CARE BEYOND MIDLIFE Thalassemia and Sickle Cell Diseases: Effect of Aging
705PDF: 700Suppl. Files: 101HTML: 180 -
NOVEL AGENTS AND EMERGING STRATEGIES FOR TARGETING THE B-CELL RECEPTOR PATHWAY IN CLL
2748PDF: 941HTML: 9092Efremov 1: 291Efremov 2: 262 -
THE ROLE OF AUTOLOGOUS AND ALLOGENEIC STEM CELL TRANSPLANTATION IN FOLLICULAR LYMPHOMA IN THE NEW DRUGS ERA.
4280PDF: 1266HTML: 2140Fig.1: 256Fig. 2: 152Table 1: 266Table2: 295Table 3: 288 -
Acquired Sideroblastic Anemia: An exploratory Comparative Statistical Analysis Between Clonal and Non-clonal cases Acquired Sideroblastic Anemia
1328PDF: 770HTML: 526 -
Pidotimod in paucisymptomatic SARS-CoV2 infected patients Pidotimod in COVID-19
3383PDF: 1991HTML: 1012 -
ALLOGENEIC TRANSPLANTATION FOR CHRONIC LYMPHOCYTIC LEUKEMIA
1558PDF: 895HTML: 1047 -
ACQUIRED REFRACTORY IRON DEFICIENCY
3891PDF: 1332HTML: 1686







